Kunming Pharmaceuticals, Inc.
Clinical trials sponsored by Kunming Pharmaceuticals, Inc., explained in plain language.
Chinese pharmaceutical company producing traditional and modern medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a plant extract help calm delirium? first human trial begins Results expected Sep 2026 (estimated)
- New stroke drug shows promise in early trial Results expected Oct 2026 (estimated)